Broadleaf Partners, LLC Abb Vie Inc. Transaction History

Broadleaf Partners, LLC

$411 Million
Q3 2024

A detailed history of Broadleaf Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Broadleaf Partners, LLC holds 7,898 shares of ABBV stock, worth $1.39 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

7,898

Previous 7,898 -0.0%

Holding current value

$1.39 Million

Previous $1.35 Million 15.14%

% of portfolio

0.38%

Previous 0.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $1,547 - $1,807	-10 Reduced 0.13%	7,898 $1.35 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $1.26 Million - $1.44 Million	7,908 New	7,908 $1.44 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $4,408 - $5,103	-33 Reduced 0.42%	7,898 $1.18 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $331,275 - $412,250	2,500 Added 46.03%	7,931 $1.07 Million
Q4 2020 Feb 24, 2021	BUY	$80.49 - $108.67 $12,073 - $16,300	150 Added 2.84%	5,431 $582,000
Q3 2019 Oct 21, 2019	SELL	$62.98 - $75.72 $66,129 - $79,506	-1,050 Reduced 16.59%	5,281 $400,000
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $3.51 Million - $4.33 Million	-45,103 Reduced 87.69%	6,331 $584,000
Q3 2018 Oct 12, 2018	SELL	$88.91 - $98.84 $55,924 - $62,170	-629 Reduced 1.21%	51,434 $4.87 Million
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $4.67 Million - $5.53 Million	-52,063 Reduced 50.0%	52,063 $4.82 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $5.76 Million - $6.81 Million	64,102 Added 160.16%	104,126 $9.65 Million
Q1 2018 Apr 20, 2018	BUY	$92.01 - $123.21 $469,895 - $629,233	5,107 Added 14.63%	40,024 $3.79 Million
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $3.13 Million - $3.43 Million	34,917	34,917 $3.38 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadleaf Partners, LLC with notifications on news.

Account

Broadleaf Partners, LLC Abb Vie Inc. Transaction History